Phase II - sbir topic CBD192-006
Ended Definitive Contract Awarded Last action
- Contract number
- W911SR21C5049
- Awardee
-
Arisan Therapeutics Inc. UEI PYRKTQPNVJZ8
- Awarding agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Obligated
- $1,099,662
Award facts
- Contract value 100% obligated
- $1,099,662.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
- Research
- SBIR Program Phase II Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $511,942 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $587,720 |
About this award
This $1,099,662.12 federal contract award to Arisan Therapeutics Inc. was made by the Department of Defense's Joint Program Executive Office for Chemical and Biological Defense under a Small Business Innovation Research (SBIR) Phase II program. The contract is a Firm Fixed Price Definitive Contract with the purpose of conducting research and development in support of the agency's chemical and biological defense mission. Arisan Therapeutics is a small disadvantaged business that has been awarded over $5 million in federal research contracts from the Department of Health and Human Services and Department of Defense since 2020. This particular award is designated as a total small business set aside.
Quick answers
Who was awarded contract W911SR21C5049?
W911SR21C5049 was awarded to Arisan Therapeutics Inc. by ACC Aberdeen Proving Ground (Army Contracting Command) on September 30, 2021.
How much is contract W911SR21C5049 worth?
The government has obligated $1,099,662 on W911SR21C5049.
Which agency awarded contract W911SR21C5049?
ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911SR21C5049, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).
Was contract W911SR21C5049 competed?
The extent of competition for W911SR21C5049 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award